News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,344 Results
Type
Article (29494)
Company Profile (196)
Press Release (666714)
Multimedia
Podcasts (139)
Webinars (21)
Section
Business (229545)
Career Advice (1236)
Deals (35552)
Drug Delivery (154)
Drug Development (77031)
Employer Resources (111)
FDA (16213)
Job Trends (13683)
News (337618)
Policy (31082)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1362)
Accelerated approval (55)
ADA (38)
Adcomms (24)
Allergies (188)
Alliances (49297)
ALS (184)
Alzheimer's disease (1521)
Antibody-drug conjugate (ADC) (475)
Approvals (16817)
Artificial intelligence (672)
ASCO (264)
Autoimmune disease (337)
Automation (59)
Bankruptcy (351)
Best Places to Work (10272)
BIO (60)
Biologics (1)
BIOSECURE Act (17)
Biosimilars (257)
BioSpace Insights (112)
Biotechnology (120)
Bladder cancer (200)
Brain cancer (61)
Breast cancer (689)
Cancer (5568)
Cardiovascular disease (448)
Career advice (1058)
Career pathing (22)
CAR-T (337)
CDC (33)
Celiac Disease (1)
Cell therapy (932)
Cervical cancer (49)
Clinical research (68489)
Collaboration (2165)
Commercialization (6)
Company closure (3)
Compensation (1575)
Complete response letters (87)
COVID-19 (2011)
CRISPR (101)
C-suite (1224)
Cystic fibrosis (146)
Data (8136)
Decentralized trials (1)
Denatured (32)
Depression (165)
Dermatology (98)
Diabetes (617)
Diagnostics (6350)
Digital health (58)
Diversity (5)
Diversity, equity & inclusion (23)
Drug discovery (337)
Drug pricing (197)
Drug shortages (35)
Duchenne muscular dystrophy (298)
Earnings (92724)
Editorial (54)
Employer branding (10)
Employer resources (99)
Events (115565)
Executive appointments (1111)
FDA (20271)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (22)
Frontotemporal dementia (28)
Funding (1566)
Gene editing (214)
Generative AI (54)
Gene therapy (713)
GLP-1 (992)
Government (3658)
Grass and pollen (7)
Guidances (405)
Healthcare (14729)
Hematology (164)
HIV (79)
Huntington's disease (49)
IgA nephropathy (118)
Immunology and inflammation (250)
Immuno-oncology (94)
Indications (222)
Infectious disease (2334)
Inflammatory bowel disease (202)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (330)
Interviews (182)
IPO (16251)
IRA (47)
Job creations (3809)
Job search strategy (928)
JPM (51)
Kidney cancer (21)
Labor market (64)
Layoffs (438)
Leadership (23)
Legal (7759)
Licensing (8)
Liver cancer (84)
Longevity (28)
Lung cancer (758)
Lymphoma (434)
Machine learning (46)
Management (47)
Manufacturing (1283)
Marketing (13)
MASH (200)
Medical affairs (1)
Medical device (13423)
Medtech (13620)
Mergers & acquisitions (20630)
Metabolic disorders (1518)
mRNA (195)
Multiple sclerosis (175)
NASH (17)
Neurodegenerative disease (399)
Neuropsychiatric disorders (91)
Neuroscience (2994)
Neurotech (1)
NextGen: Class of 2026 (5171)
Non-profit (2029)
Now hiring (47)
Obesity (670)
Opinion (245)
Ovarian cancer (215)
Pain (267)
Pancreatic cancer (324)
Parkinson's disease (350)
Partnered (31)
Patents (667)
Patient recruitment (736)
Peanut (64)
People (57500)
Pharmaceutical (51)
Pharmacy benefit managers (26)
Phase 1 (21235)
Phase 2 (30073)
Phase 3 (22533)
Pipeline (10456)
Policy (282)
Postmarket research (2400)
Preclinical (8863)
Press Release (69)
Prostate cancer (300)
Psychedelics (47)
Radiopharmaceuticals (348)
Rare diseases (1089)
Real estate (5656)
Recruiting (45)
Regulatory (25427)
Reports (36)
Research institute (1396)
Resumes & cover letters (163)
Rett syndrome (45)
RNA editing (23)
RSV (75)
Schizophrenia (167)
Series A (276)
Series B (199)
Service/supplier (7)
Sickle cell disease (113)
Special edition (19)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3425)
State (2)
Stomach cancer (8)
Supply chain (143)
Tariffs (92)
The Weekly (104)
Vaccines (924)
Venture capital (82)
Weight loss (441)
Women's health (124)
Worklife (13)
Date
Today (3)
Last 7 days (612)
Last 30 days (2273)
Last 365 days (28062)
2026 (17984)
2025 (28018)
2024 (32754)
2023 (37439)
2022 (48169)
2021 (51932)
2020 (49268)
2019 (39618)
2018 (30177)
2017 (30910)
2016 (29716)
2015 (35739)
2014 (30134)
2013 (26017)
2012 (28197)
2011 (28638)
2010 (27022)
Location
Africa (628)
Alabama (86)
Alaska (3)
Arizona (366)
Arkansas (15)
Asia (40578)
Australia (6273)
California (14045)
Canada (3859)
China (1497)
Colorado (587)
Connecticut (557)
Delaware (412)
Europe (82550)
Florida (2113)
Georgia (446)
Hawaii (5)
Idaho (58)
Illinois (1094)
India (109)
Indiana (638)
Iowa (22)
Japan (629)
Kansas (134)
Kentucky (45)
Louisiana (39)
Maine (91)
Maryland (1624)
Massachusetts (9898)
Michigan (404)
Minnesota (747)
Mississippi (7)
Missouri (159)
Montana (31)
Nebraska (20)
Nevada (152)
New Hampshire (86)
New Jersey (3745)
New Mexico (29)
New York (3513)
North Carolina (1762)
North Dakota (8)
Northern California (7173)
Ohio (389)
Oklahoma (23)
Oregon (36)
Pennsylvania (2638)
Puerto Rico (29)
Rhode Island (43)
South America (990)
South Carolina (87)
South Dakota (1)
Southern California (5592)
Tennessee (209)
Texas (2208)
United States (48838)
Utah (419)
Vermont (2)
Virginia (340)
Washington D.C. (62)
Washington State (1109)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
696,344 Results for "tap pharmaceutical products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
April 23, 2026
·
5 min read
China
AstraZeneca taps China’s CSPC again, betting up to $1.77B to target kidney diseases
AstraZeneca and CSPC Pharmaceutical Group have already inked two other agreements this year, including an obesity-focused deal in January and one focused on chronic diseases in June.
July 2, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR T therapy
ElevateBio will be the primary source of Kyverna’s autologous CAR T cell therapy for anticipated U.S. and global launches in autoimmune indications.
July 29, 2026
·
2 min read
·
Nick Paul Taylor
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
GSK and Hansoh Pharmaceutical’s antibody-drug conjugate success validates their partnership, one of the many deals in which Big Pharma has tapped a China company for promising cancer candidates.
July 10, 2026
·
1 min read
·
Gabrielle Masson
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
With PolyPeptide manufacturing peptides such as GLP-1 medicines, Samsung Biologics has identified the deal as a way to tap into fast-growing demand for obesity drug production services.
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
May 4, 2026
·
4 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend
August 4, 2026
·
1 min read
Policy
FDA taps prior knowledge to expedite cell and gene therapy development
A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns surface about the politicization of the agency.
June 3, 2026
·
12 min read
·
BioSpace Editorial Staff
Press Releases
Nephrodite’s Holly™ Implantable Continuous Dialysis System Awarded Selection into FDA’s TAP to Accelerate Development and Patient Access
June 3, 2026
·
3 min read
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals Finalize Joint Venture and Launch First Brand Product
May 14, 2026
·
3 min read
1 of 69,635
Next
